位置:首页 > 蛋白库 > PA2H5_TRIGA
PA2H5_TRIGA
ID   PA2H5_TRIGA             Reviewed;         138 AA.
AC   P70090; P87482;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   25-MAY-2022, entry version 97.
DE   RecName: Full=Basic phospholipase A2 homolog 5;
DE            Short=svPLA2 homolog;
DE   AltName: Full=Phospholipase A2 isozyme V;
DE            Short=PLA2-V;
DE   Flags: Precursor;
OS   Trimeresurus gramineus (Bamboo pit viper) (Indian green tree viper).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata; Toxicofera;
OC   Serpentes; Colubroidea; Viperidae; Crotalinae; Trimeresurus.
OX   NCBI_TaxID=8767;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RC   TISSUE=Venom gland;
RX   PubMed=7777556; DOI=10.1073/pnas.92.12.5605;
RA   Nakashima K., Nobuhisa I., Deshimaru M., Nakai M., Ogawa T.,
RA   Shimohigashi Y., Fukumaki Y., Hattori M., Sakaki Y., Hattori S., Ohno M.;
RT   "Accelerated evolution in the protein-coding regions is universal in
RT   crotalinae snake venom gland phospholipase A2 isozyme genes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:5605-5609(1995).
RN   [2]
RP   PROTEIN SEQUENCE OF 17-138, AND SUBCELLULAR LOCATION.
RC   TISSUE=Venom;
RX   PubMed=8744986; DOI=10.1016/0041-0101(95)00090-9;
RA   Nakai M., Nakashima K., Ogawa T., Shimohigashi Y., Hattori S., Chang C.-C.,
RA   Ohno M.;
RT   "Purification and primary structure of a myotoxic lysine-49 phospholipase
RT   A2 with low lipolytic activity from Trimeresurus gramineus venom.";
RL   Toxicon 33:1469-1478(1995).
CC   -!- FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic
CC       activity (By similarity). Is myotoxic and displays edema-inducing
CC       activities (By similarity). A model of myotoxic mechanism has been
CC       proposed: an apo Lys49-PLA2 is activated by the entrance of a
CC       hydrophobic molecule (e.g. fatty acid) at the hydrophobic channel of
CC       the protein leading to a reorientation of a monomer (By similarity).
CC       This reorientation causes a transition between 'inactive' to 'active'
CC       states, causing alignment of C-terminal and membrane-docking sites
CC       (MDoS) side-by-side and putting the membrane-disruption sites (MDiS) in
CC       the same plane, exposed to solvent and in a symmetric position for both
CC       monomers (By similarity). The MDoS region stabilizes the toxin on
CC       membrane by the interaction of charged residues with phospholipid head
CC       groups (By similarity). Subsequently, the MDiS region destabilizes the
CC       membrane with penetration of hydrophobic residues (By similarity). This
CC       insertion causes a disorganization of the membrane, allowing an
CC       uncontrolled influx of ions (i.e. calcium and sodium), and eventually
CC       triggering irreversible intracellular alterations and cell death (By
CC       similarity). {ECO:0000250|UniProtKB:I6L8L6,
CC       ECO:0000250|UniProtKB:Q90249}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:7777556}.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC       {ECO:0000305|PubMed:7777556}.
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II subfamily.
CC       K49 sub-subfamily. {ECO:0000305}.
CC   -!- CAUTION: Does not bind calcium as one of the calcium-binding sites is
CC       lost (Asp->Lys in position 64, which corresponds to 'Lys-49' in the
CC       current nomenclature). {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA06553.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D31775; BAA06553.1; ALT_INIT; mRNA.
DR   EMBL; D31781; BAA06559.1; -; Genomic_DNA.
DR   AlphaFoldDB; P70090; -.
DR   SMR; P70090; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:InterPro.
DR   GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR   GO; GO:0050482; P:arachidonic acid secretion; IEA:InterPro.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:InterPro.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   CDD; cd00125; PLA2c; 1.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR033112; PLipase_A2_Asp_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   InterPro; IPR036444; PLipase_A2_dom_sf.
DR   InterPro; IPR033113; PLipase_A2_His_AS.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Disulfide bond; Myotoxin; Secreted; Signal;
KW   Toxin.
FT   SIGNAL          1..16
FT                   /evidence="ECO:0000269|PubMed:8744986"
FT   CHAIN           17..138
FT                   /note="Basic phospholipase A2 homolog 5"
FT                   /id="PRO_0000022960"
FT   REGION          121..133
FT                   /note="Important for membrane-damaging activities in
FT                   eukaryotes and bacteria; heparin-binding"
FT                   /evidence="ECO:0000250|UniProtKB:P24605"
FT   SITE            121
FT                   /note="Important residue of the cationic membrane-docking
FT                   site (MDoS)"
FT                   /evidence="ECO:0000250|UniProtKB:I6L8L6"
FT   SITE            124
FT                   /note="Important residue of the cationic membrane-docking
FT                   site (MDoS)"
FT                   /evidence="ECO:0000250|UniProtKB:I6L8L6"
FT   SITE            127
FT                   /note="Hydrophobic membrane-disruption site (MDiS)"
FT                   /evidence="ECO:0000250|UniProtKB:I6L8L6"
FT   SITE            128
FT                   /note="Cationic membrane-docking site (MDoS)"
FT                   /evidence="ECO:0000250|UniProtKB:I6L8L6"
FT   SITE            130
FT                   /note="Hydrophobic membrane-disruption site (MDiS)"
FT                   /evidence="ECO:0000250|UniProtKB:I6L8L6"
FT   SITE            133
FT                   /note="Cationic membrane-docking site (MDoS)"
FT                   /evidence="ECO:0000250|UniProtKB:I6L8L6"
FT   DISULFID        42..131
FT                   /evidence="ECO:0000250|UniProtKB:Q90249"
FT   DISULFID        44..60
FT                   /evidence="ECO:0000250|UniProtKB:Q90249"
FT   DISULFID        59..111
FT                   /evidence="ECO:0000250|UniProtKB:Q90249"
FT   DISULFID        65..138
FT                   /evidence="ECO:0000250|UniProtKB:Q90249"
FT   DISULFID        66..104
FT                   /evidence="ECO:0000250|UniProtKB:Q90249"
FT   DISULFID        73..97
FT                   /evidence="ECO:0000250|UniProtKB:Q90249"
FT   DISULFID        91..102
FT                   /evidence="ECO:0000250|UniProtKB:Q90249"
SQ   SEQUENCE   138 AA;  15690 MW;  238F3A2FF131113F CRC64;
     MRTLWIMAVL LLGVEGSVIE LGKMIFQETG KNPATSYGLY GCNCGPGGRR KPKDATDRCC
     YVHKCCYKKL TDCDPIKDRY SYSWVNKAIV CGEDNPCLKE MCECDKAVAI CFRENLDTYD
     KKKKINLKLF CKKTSEQC
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024